Novel Proactive Model Identifies Falls, Syncope, Dizziness

This article originally appeared here.
Share this content:
Novel Proactive Model Identifies Falls, Syncope, Dizziness
Novel Proactive Model Identifies Falls, Syncope, Dizziness

MONDAY, Oct. 3, 2016 (HealthDay News) -- A novel proactive multidisciplinary service model can identify falls, syncope, and dizziness symptoms, and reveal new diagnoses, according to a study published online Sept. 27 in the Journal of the American Geriatrics Society.

Steve W. Parry, M.B.B.S., Ph.D., of the Newcastle Hospitals NHS Foundation Trust in the United Kingdom, and colleagues designed a novel multidisciplinary, multifactorial falls, syncope, and dizziness service model with enhanced case ascertainment through proactive, primary care-based screening for individual fall risk factors.

The researchers identified 4,039 individuals through the service model, of whom 2,232 had significant gait and balance abnormalities, according to assessment by a senior physical therapist. Significant numbers of individuals were identified with new diagnoses, including cognitive impairment and Parkinson's disease, as well as urgent indications for a pacemaker. According to the World Health Association Fracture Risk Assessment Tool Score, more than 600 individuals were at high risk of osteoporosis; 173 had benign positional paroxysmal vertigo and 50 had atrial fibrillation.

"Through such screening and this approach, Comprehensive Geriatric Assessment Plus (Plus [referring to] falls, syncope and dizziness expertise), unmet need was targeted on a scale far outside the numbers seen in clinical trials," the authors write. "Further work is needed to determine whether this approach translates into fewer falls and decreases in syncope and dizziness."

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!

Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease

Trending Activities

All Professions



Sign up for myCME e-newsletters


More in Home

FDA Approves First Drug for Rare Form of Rickets

FDA Approves First Drug for Rare Form of ...

Crysvita approved for adults and children ages 1 year and older with x-linked hypophosphatemia

High FGF-23 Linked to Recurrent Cardiac Events After ACS

High FGF-23 Linked to Recurrent Cardiac Events After ...

FGF-23 in top quartile independently linked to greater risk of CV death, heart failure hospitalization

Medical Cannabis Not Recommended for Sleep Apnea

Medical Cannabis Not Recommended for Sleep Apnea

American Academy of Sleep Medicine says evidence insufficient to recommend cannabis for apnea

is free, fast, and customized just for you!

Already a member?

Sign In Now »